Covered recipient · General Payments record
JOSEPH L CLAIBORNE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2020–2025
$4,635.50
- Reported across 254 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $199.94 | 9 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Almirall LLC | $54.99 | 2 |
| ABBVIE INC. | $54.61 | 2 |
| Lilly USA, LLC | $21.90 | 1 |
| Acerta Pharma LLC | $18.55 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $18.01 | 1 |
| Currax Pharmaceuticals LLC | $17.62 | 1 |
| Supernus Pharmaceuticals, Inc. | $14.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.70 | 02/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201666818 | CMS |
| ABBVIE INC. | $31.91 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201666820 | CMS |
| Almirall LLC | $29.53 | 01/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243872389 | CMS |
| Almirall LLC | $25.46 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243872415 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.55 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206197670 | CMS |
| Currax Pharmaceuticals LLC | $17.62 | 04/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242704306 | CMS |
| Lilly USA, LLC | $21.90 | 07/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186678907 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $18.01 | 09/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251014987 | CMS |
| Supernus Pharmaceuticals, Inc. | $14.26 | 05/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244918155 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2020, 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.